Clinical Trials Logo
  1. Home
  2. Wolman Disease
  3. NCT01358370

A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype

Lysosomal Acid Lipase Deficiency Clinical Trial

Official title:
A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype

Clinical Trial Summary

This is a Natural History study to characterize key aspects of the clinical course of lysosomal acid lipase (LAL) deficiency/Wolman phenotype in patients.

Clinical Trial Description

The objective of this study is to characterize key aspects of the clinical course of LAL deficiency/Wolman phenotype in patients including, but not limited to, survival and growth parameters, to serve as a historical control to inform the evaluation and care of affected patients and to provide a reference for efficacy studies of enzyme replacement or other novel therapies. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01358370
Study type Observational
Source Alexion Pharmaceuticals
Contact
Status Completed
Phase N/A
Start date November 2010
Completion date March 2013
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Recruiting NCT03984149 - Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects)
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Recruiting NCT03564002 - Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity
Terminated NCT02926872 - Screening for Lysosomal Acid Lipase Deficiency N/A
Terminated NCT01473875 - Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102 Phase 2/Phase 3
Completed NCT01371825 - Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency Phase 2/Phase 3
Enrolling by invitation NCT05368038 - ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
Terminated NCT02193867 - Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency Phase 2
Completed NCT02112994 - Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency Phase 2
Completed NCT01528917 - An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype N/A
Completed NCT01757184 - Acid Lipase Replacement Investigating Safety and Efficacy (ARISE) in Participants With Lysosomal Acid Lipase Deficiency Phase 3
Recruiting NCT01633489 - Lysosomal Acid Lipase (LAL) Deficiency Registry
Terminated NCT02345421 - A Study to Identify and Characterize LAL-D Patients in High-risk Populations N/A
Completed NCT01488097 - Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency Phase 2
Enrolling by invitation NCT01716728 - Identification of Undiagnosed Lysosomal Acid Lipase Deficiency N/A
Completed NCT01307098 - Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency Phase 1/Phase 2
No longer available NCT02376751 - An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency N/A